Results 121 to 130 of about 3,733 (171)

Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol. [PDF]

Trials
Briskey D, Pellow J, Beatson G, Tremblay A, Rao A, Tompkins TA.   +5 more
europepmc   +1 more source

A Streamlined Treatment Algorithm for Allergic Rhinitis in the Arab Region: Expert Panel Opinion. [PDF]

Cureus
Armouch MC, Atef AM, Abdel Hameed O, Alshaikh NA, Elbeleidy AS, Ali B, El Najjar L, Tawfik E.   +7 more
europepmc   +1 more source

Chinese Guidelines for Diagnosis and Treatment of Chronic Rhinosinusitis (2024). [PDF]

World J Otorhinolaryngol Head Neck Surg
Subspecialty Group of Rhinology, Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, Subspecialty Group of Rhinology, Society of Otorhinolaryngology Head and Neck Surgery, Chinese Medical Association.   +4 more
europepmc   +1 more source

An Atypical Presentation of Aggressive Oral Pyogenic Granuloma With Oroantral Communication and Bone Erosion. [PDF]

Cureus
Gupta C, Agha N, Chakraborty S, Khan T, Mishra A.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extended Use of Topical Nasal Decongestants

Laryngoscope, 1997
AbstractUse of sympathomimetic topical nasal decongestants to treat nasal obstruction is usually restricted to 3 to 5 days to avoid potential rebound swelling (rhinitis medicamentosa). In this study, 10 healthy volunteers used oxymetazoline (long‐acting topical nasal decongestant) nightly for 4 weeks.
Hadi Seikaly, K H Calhoun
exaly   +3 more sources

α2-adrenoceptor agonists as nasal decongestants

Pulmonary Pharmacology and Therapeutics, 2007
Nasal congestion, one of the major disease features of rhinitis, is induced by the filling of venous sinusoids causing mucosal engorgement with resultant obstruction of nasal airflow. The only available drugs that directly target the underlying vascular features driving nasal obstruction are the sympathomimetic alpha-adrenoceptor agonists due to their ...
J A Hey
exaly   +3 more sources

Topical Nasal Decongestants

American Pharmacy, 1992
Janet P Engle
exaly   +3 more sources

Nasal Decongestants

2015
Daniel Ginat, Ginat Daniel Thomas
exaly   +2 more sources

Nasal Decongestants

Drugs, 1981
When a patient presents with nasal obstruction a correct diagnosis must be made. Treatment may not always be required, and the need for intervention should be balanced against the risks of therapy. If the patient has an acute problem, such as the common cold or sinusitis, a topical decongestant may be the most immediately effective remedy, but this ...
D W, Empey, K T, Medder
openaire   +2 more sources

Effect of Nasal Decongestion on Nasalance Measures

The Cleft Palate-Craniofacial Journal, 2005
Objective The purpose of this study was to evaluate the effect of nasal decongestant on nasalance scores for a group of 100 individuals. Participants Forty-one subjects with hypernasality and 59 subjects without hypernasality underwent
Maria Inês, Pegoraro-Krook, Jeniffer C R, Dutka-Souza, William N, Williams, Lídia C, Teles Magalhães, Patrícia Cortez, Rossetto, John E, Riski   +5 more
openaire   +2 more sources